Related Experiment Video
Updated: May 9, 2026

Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
Effect of diabetes/hyperglycemia on the rat retinal adenosinergic system
Joana Vindeirinho1, Gabriel N Costa, Mariana B Correia
1CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Abstract:
The early stages of diabetic retinopathy (DR) are characterized by alterations similar to neurodegenerative and inflammatory conditions such as increased neural apoptosis, microglial cell activation and amplified production of pro-inflammatory cytokines. Adenosine regulates several physiological functions by stimulating four subtypes of receptors, A1AR, A2AAR, A2BAR, and A3AR. Although the adenosinergic signaling system is affected by diabetes in several tissues, it is unknown whether diabetic conditions in the retina can also affect it. Adenosine delivers potent suppressive effects on virtually all cells of the immune system, but its potential role in the context of DR has yet to be studied in full. In this study, we used primary mixed cultures of rat retinal cells exposed to high glucose conditions, to mimic hyperglycemia, and a streptozotocin rat model of type 1 diabetes to determine the effect diabetes/hyperglycemia have on the expression and protein levels of adenosine receptors and of the enzymes adenosine deaminase and adenosine kinase. We found elevated mRNA and protein levels of A1AR and A2AAR, in retinal cell cultures under high glucose conditions and a transient increase in the levels of the same receptors in diabetic retinas. Adenosine deaminase and adenosine kinase expression and protein levels showed a significant decrease in diabetic retinas 30 days after diabetes induction. An enzymatic assay performed in retinal cell cultures revealed a marked decrease in the activity of adenosine deaminase under high glucose conditions. We also found an increase in extracellular adenosine levels accompanied by a decrease in intracellular levels when retinal cells were subjected to high glucose conditions. In conclusion, this study shows that several components of the retinal adenosinergic system are affected by diabetes and high glucose conditions, and the modulation observed may uncover a possible mechanism for the alleviation of the inflammatory and excitotoxic conditions observed in diabetic retinas.
Insights
Diabetic retinopathy (DR) alters the retinal adenosinergic system. High glucose and diabetes increase adenosine receptors (A1AR, A2AAR) while decreasing adenosine deaminase and kinase, potentially alleviating inflammation.
Area of Science:
- Ophthalmology
- Neuroscience
- Endocrinology
Background:
- Diabetic retinopathy (DR) shares features with neurodegenerative and inflammatory conditions.
- Adenosine signaling, involving A1AR, A2AAR, A2BAR, and A3AR, regulates physiological functions.
- The impact of diabetes on the retinal adenosinergic system remains largely unstudied.
Purpose of the Study:
- To investigate the effects of diabetes and hyperglycemia on the retinal adenosinergic system.
- To examine changes in adenosine receptors and key enzymes (adenosine deaminase, adenosine kinase) in diabetic retinas.
Main Methods:
- Primary rat retinal cell cultures exposed to high glucose.
- Streptozotocin-induced type 1 diabetes model in rats.
- Analysis of mRNA, protein levels, enzyme activity, and extracellular/intracellular adenosine.
Main Results:
- Elevated A1AR and A2AAR mRNA and protein levels in high glucose conditions and diabetic retinas.
- Decreased adenosine deaminase and adenosine kinase in diabetic retinas.
- Reduced adenosine deaminase activity, increased extracellular adenosine, and decreased intracellular adenosine under high glucose.
Conclusions:
- Diabetes and hyperglycemia significantly affect retinal adenosinergic system components.
- Observed modulations suggest a potential mechanism for mitigating inflammation and excitotoxicity in diabetic retinas.
Related Concept Videos
Diabetic Retinopathy
Diabetic Nephropathy
Diabetic Neuropathy
Hyperglycemia
Diabetes Insipidus II: Pathophysiology

